[["IgG"],["IgG"],["IgG"],["IgG"],["Grade "],["Grade "],["Grade "],["Grade "],["Grade "],["Grade "],["Grade "],["First edition published 199"],["Second edition published 200"],["Third edition published 201"],["Index 61"],["Th1"],["Part "],["Introduction "],["Laboratory investigation "],["Major B-lymphocyte disorders "],["Autosomal hyper-IgM syndromes 2"],["Transient hypogammaglobulinaemia of infancy (THI) 2"],["Chapter "],["Disorders with predominant T-cell disorder 4"],["DiGeorge (22q11 deletion complex) syndrome 4"],["Ataxia telangiectasia 4"],["Other chromosomal instability disorders 5"],["Chronic mucocutaneous candidiasis (CMC) syndromes 5"],["Idiopathic CD4+ T-cell lymphopenia 5"],["Canale–Smith syndrome) 5"],["Cartilage–hair hypoplasia (CHH) syndrome 5"],["Mendelian susceptibility to mycobacterial disease (MSMD) 6"],["Toll-like receptor (TLR) defects 6"],["Phagocytic cell defects 6"],["Chronic granulomatous disease 6"],["Other phagocytic cell defects 6"],["Cyclic neutropenia 6"],["Other neutrophil defects 6"],["Hypercatabolism of immunoglobulin 7"],["Splenic disorders 7"],["Miscellaneous host defence disorders 7"],["Websites 7"],["This rare autosomal recessive syndrome is due to mutations in the COH"],["Hermansky–Pudlak syndrome type "],["Chapter "],["Introduction 8"],["Epstein–Barr virus 8"],["Other viral infections 8"],["Acute bacterial infections 9"],["Chronic bacterial sepsis 9"],["Bronchiectasis 9"],["Fungal and parasitic infections 9"],["Malignancy 9"],["Myeloma 9"],["Chronic lymphocytic leukaemia (CLL) 10"],["Acute leukaemias 10"],["Bone marrow and stem cell transplantation 10"],["Acute leukaemias 10"],["Transfusion therapy 10"],["Chronic renal disease (nephrotic syndrome and uraemia) 10"],["Protein-losing enteropathy and liver disease (cirrhosis) 10"],["Metabolic disorders 11"],["Diabetes mellitus 11"],["Asplenia 11"],["Drugs and toxins 11"],["Burns 11"],["Thoracic duct drainage 11"],["Cardiac surgery in children 11"],["Physical and environmental factors 11"],["Proteus syndrome 11"],["Yellow nail syndrome 11"],["Chapter "],["Introduction 12"],["Anaphylaxis 12"],["Management of anaphylaxis 12"],["Anaphylactoid reactions 12"],["Angioedema 12"],["Urticaria 1 12"],["Urticarial vasculitis 13"],["Mastocytosis 13"],["Histamine intolerance 13"],["Asthma 1 13"],["Sulphite sensitivity 13"],["Aspirin sensitivity 13"],["Allergic rhinitis 13"],["Allergic conjunctivitis 14"],["Sinusitis 14"],["Secretory otitis media (glue ear) 14"],["Atopic eczema (dermatitis) 14"],["Contact dermatitis (hypersensitivity) 14"],["Itch (pruritus) 14"],["Food allergy 1 14"],["Contact allergy to food 15"],["Oral allergy syndrome 15"],["Latex allergy 15"],["Vaccine reactions 16"],["Venom allergy 16"],["Extrinsic allergic alveolitis (EAA) 16"],["Allergic bronchopulmonary aspergillosis (ABPA) 16"],["Other pulmonary eosinophilic syndromes 16"],["Allergic renal disease 16"],["Hyper-eosinophilic syndromes (HES) 16"],["Websites 16"],["Urticaria "],["Asthma "],["The loci involved are controversial, with loci on chromosome "],["Food allergy "],["Cor a"],["Ara h"],["Gly m"],["Cor a"],["Ara h"],["Cor a"],["Ara h"],["Gly m"],["Ara h1, h2, h"],["Chapter "],["Subacute thyroiditis syndromes 17"],["Primary hypothyroidism and sporadic goitre 17"],["Thyroid disease and other symptoms 17"],["Type I diabetes (insulin-dependent) 17"],["Immunological complications of insulin therapy 17"],["Pernicious anaemia 18"],["Pituitary autoimmunity 18"],["Parathyroid autoimmunity 18"],["Vitiligo and alopecia 18"],["Chapter "],["Myasthenia gravis (MG) 18"],["Lambert–Eaton myasthenic syndrome (LEMS) 18"],["Rasmussen encephalitis 19"],["Paraneoplastic autoimmune neurological syndromes 19"],["Autoimmune encephalopathies 19"],["Primary angiitis of the central nervous system (PACNS) 19"],["Purkinje cells and recognizing two antigens of molecular weights 3"],["Chapter "],["Chapter "],["Autoimmune enteropathy 21"],["Achalasia 21"],["Eosinophilic gastroenteritis (including oesophagitis) 21"],["Ulcerative colitis (UC) 21"],["Coeliac disease 21"],["Sclerosing mesenteritis 22"],["Autoimmune pancreatitis 22"],["Irritable bowel syndrome (IBS) 22"],["Chapter "],["Primary biliary cirrhosis (PBC) 22"],["Autoimmune hepatitis 22"],["Primary sclerosing cholangitis 22"],["Chapter "],["Immune thrombocytopenia (ITP) 23"],["Autoimmune haemolytic anaemia 23"],["Autoimmune neutropenia 23"],["Paroxysmal nocturnal haemoglobinuria (PNH) 23"],["Aplastic anaemia (AA) and pure red cell aplasia 23"],["Anti-factor VIII antibodies (acquired haemophilia) 23"],["Heparin-induced thrombocytopenia (HIT) 23"],["Chapter 1"],["Overview 24"],["Bullous pemphigoid 24"],["Herpes gestationis and cicatricial pemphigoid 24"],["Pemphigus vulgaris 24"],["Pemphigus foliaceus 24"],["Paraneoplastic pemphigus 24"],["Epidermolysis bullosa acquisita 24"],["Dermatitis herpetiformis (DH) and linear IgA disease 24"],["Erythema multiforme (EM) 24"],["Lichen planus (LP) 24"],["Alopecia areata 24"],["Vitiligo 24"],["Psoriasis 24"],["Website 25"],["Chapter 1"],["Overview 25"],["Uveitis 25"],["Tubulointerstitial nephritis and uveitis (TINU) 25"],["Vogt–Koyanagi–Harada disease (VKH) 25"],["Cancer-associated retinopathy and uveitis 25"],["Birdshot retinopathy 25"],["Scleritis 25"],["Ocular cicatricial pemphigoid 25"],["Sympathetic ophthalmitis 25"],["Chapter 1"],["Psoriatic arthritis 26"],["Systemic lupus erythematosus (SLE) and variants 26"],["Drug-related lupus (DRL) 27"],["IgG4-related chronic sclerosing dacryoadenitis 28"],["Undifferentiated connective tissue disease 28"],["Mixed connective tissue disease (MCTD) 28"],["Overlap syndromes 28"],["Scleroderma mimics 29"],["Anti-phospholipid syndrome (APS) 29"],["Livedo reticularis 29"],["Rheumatic fever 29"],["Fibromyalgia 30"],["Websites 30"],["Associated with HLA-DR"],["Anti-Scl-7"],["Chapter 1"],["Causes of vasculitis 30"],["Diagnostic tests 30"],["Microscopic polyarteritis (MPA) 30"],["Primary angiitis of the CNS (PACNS) 30"],["Polyarteritis nodosa (PAN) 31"],["Churg–Strauss syndrome (CSS) 31"],["Lymphomatoid granulomatosis 32"],["Erythema elevatum diutinum 32"],["Erythema nodosum 32"],["Weber–Christian disease (relapsing febrile panniculitis) 32"],["Relapsing polychondritis 32"],["Infection as a trigger of vasculitis 32"],["Malignancy-associated vasculitis 33"],["Drug-related vasculitis 33"],["Atrial myxoma and serum sickness 33"],["Websites 33"],["Parvovirus B1"],["Chapter 1"],["Sarcoidosis 33"],["Amyloidosis 33"],["Other acquired amyloidoses 34"],["Familial Mediterranean fever (FMF) 34"],["Hibernian fever) 34"],["Hyper-IgD syndrome 34"],["Muckle–Wells and related syndromes 34"],["Blau syndrome 34"],["Xanthogranulomatosis 34"],["Satoyoshi syndrome (Komura–Guerri syndrome) 34"],["Chronic fatigue syndrome (CFS) 1 34"],["Idiopathic oedema 35"],["Macrophagic myofasciitis 35"],["Burning mouth syndrome 35"],["Postural orthostatic tachycardia syndrome (POTS) 35"],["Sports immunology 1 35"],["Depression and immune function 35"],["Immunology of infection 36"],["Immunological diseases of pregnancy 1 36"],["Chronic fatigue syndrome (CFS) "],["Sports immunology "],["Immunological diseases of pregnancy "],["Chapter 1"],["Gene therapy 37"],["Graft-versus-host disease (GvHD) 37"],["Acute GvHD (aGvHD) 37"],["Chronic GvHD (cGvHD) 37"],["Graft-versus-tumour (GvT) effect 37"],["Graft failure 37"],["Solid organ transplantation 1 37"],["Solid organ transplantation "],["Chapter 1"],["Introduction 38"],["Passive immunization 38"],["Active immunization 38"],["Immune stimulation 39"],["Anti-CD25 agents 41"],["Photopheresis 42"],["Thoracic duct drainage 42"],["Plasmapheresis 42"],["Immunoadsorption 42"],["Adoptive immunotherapy 42"],["Monitor liver function (alternate infusions, minimum every 3–"],["Chapter 1"],["Techniques 43"],["Amyloid proteins 44"],["Avian precipitins 44"],["Bence-Jones proteins 44"],["Caeruloplasmin 44"],["Complement allotypes 44"],["Complement factors H and I 45"],["Cryoglobulins 45"],["Fungal precipitins 45"],["Haptoglobin 45"],["Anti-IgA antibodies 45"],["IgA subclasses and IgD 45"],["Immunoglobulins (total serum) "],["IgG subclasses 46"],["Immune complexes 46"],["Isohaemagglutinins 46"],["Mannose-binding lectin (MBL) 46"],["Neopterin and orosomucoid 46"],["Pyroglobulins 46"],["Transferrin 46"],["Urine free light chains 47"],["Viral antibodies 47"],["Viscosity 47"],["Low C4, normal C"],["Normal C4, low C"],["Low C4, low C"],["Immunoglobulins (total serum) "],["Chapter 1"],["Introduction 47"],["Particle agglutination assays 47"],["Immunoprecipitation assays 47"],["Radio-immunoassay (RIA) 48"],["Immunoblotting 48"],["Actin antibodies 48"],["Amphiphysin antibodies 48"],["Aquaporin antibodies 48"],["Cardiac antibodies 48"],["Cartilage antibodies 48"],["Centriole antibodies 48"],["Cold agglutinins 48"],["Endomysial antibodies (EMA) 49"],["Endothelial antibodies 49"],["Erythrocyte antibodies 49"],["Ganglioside antibodies 49"],["Gliadin antibodies (AGA) 49"],["Gut (enterocyte) antibodies 50"],["Heterophile antibodies 50"],["Histone antibodies 50"],["Hsp-90 antibodies 50"],["Hu antibodies 50"],["Inner ear antibodies 50"],["Insulin antibodies (IAA) 50"],["Intrinsic factor antibodies 50"],["Islet cell antibodies (ICA) 50"],["Ki and Ku antibodies 50"],["La (SS-B) antibodies 50"],["Ma antibodies 50"],["Mi-2 antibodies 50"],["Mitochondrial M2 antibodies 50"],["MuSK antibodies 50"],["Multiple nuclear dot antibody 50"],["Nephritic factors 51"],["Neutrophil antibodies 51"],["Nuclear antibodies (ANA) 51"],["Nuclear matrix antibodies 51"],["Nuclear pore antibodies 51"],["Nucleolar antibodies 51"],["Ovarian antibodies 51"],["Parathyroid antibodies 51"],["Pituitary gland antibodies 51"],["Platelet antibodies 51"],["Purkinje cell antibodies 52"],["Recoverin antibodies 52"],["Reticulin antibodies 52"],["Rheumatoid factor (RhF) 52"],["Ri antibodies 52"],["Ro (SS-A) antibodies 52"],["Salivary gland antibodies 52"],["Scl-70 antibodies 52"],["Sm (Smith) antibodies 52"],["Sperm antibodies 52"],["Steroid cell antibodies 52"],["Striated muscle antibodies 52"],["Thyroglobulin antibodies 52"],["Thyroid orbital antibodies 53"],["Tr antibodies 53"],["Vimentin antibodies 53"],["Yo antibodies 53"],["Zic4 antibodies 53"],["Proteinase "],["Ro, La, Mi-"],["Topoisomerase "],["Nuclear dots (2–6) Nsp-"],["Sp10"],["Cytokeratin 1"],["Chapter 1"],["Introduction 53"],["Basophil activation test 53"],["Challenge tests 53"],["Drug allergy testing 54"],["Eosinophil cationic protein (ECP) 54"],["Eosinophil count 54"],["Histamine-release assays 54"],["Immunoglobulin E (total IgE) 54"],["IgG to food allergens 54"],["Mast-cell tryptase 54"],["Omalizumab monitoring by basophil-bound IgE 54"],["Patch testing 54"],["Thromboxanes and prostaglandins 55"],["Unvalidated tests 55"],["Urinary methyl histamine 55"],["ImmunoCAP contains very little of the recombinant allergen rGly m"],["Chapter 2"],["Introduction 55"],["Flow cytometry 55"],["Tissue culture 55"],["Proliferation assays 55"],["Immunohistology 55"],["Cytokine, chemokine, soluble protein assays 55"],["Apoptosis assays 55"],["Adhesion markers 55"],["Bronchoalveolar lavage (BAL) studies 56"],["Complement membrane regulatory factors 56"],["Cytokine and cytokine receptor measurement 56"],["Cytotoxic T cells 56"],["Genetic and protein studies 56"],["Leukaemia phenotyping 56"],["Lymphocyte subsets 56"],["Lymphoma diagnosis 57"],["Neutrophil function testing 57"],["Perforin expression 57"],["Toll-like receptors (TLRs) 57"],["IgG, IgG"],["IgG, IgG"],["IgG, IgG"],["IgG, IgG"],["IgG, IgM, IgG1, IgG"],["IgG, IgM, IgG1, IgG"],["IgG, IgG1, IgG"],["Chapter 2"],["Introduction 58"],["Mixed lymphocyte reaction (MLR) 58"],["Molecular HLA typing 58"],["Human anti-animal antibodies 58"],["Chimerism studies 58"],["Useful websites 58"],["Chapter 2"],["Introduction 59"],["Structure of the NHS and the NHS plan 59"],["Clinical Pathology Accreditation (CPA) 59"],["Quality management system (QMS) 59"],["Concepts of quality assurance in the laboratory 59"],["Quality control (internal) 59"],["Clinical standards and audit 60"],["Health and safety 60"],["Laboratory and clinical organization 60"],["Training 60"],["Writing a business case 61"],["Applying for a consultant post 61"],["Consultant contract and private practice 61"],["Websites 61"],["Agenda for Change 61"],["Fanconi 51–"],["Barth syndrome 6"],["Blau syndrome 34"],["Commission 605–"],["Accreditation 596–"],["Cockayne syndrome 5"],["Cohen syndrome 6"],["Cusum chart 60"],["Health 592–"],["DiGeorge syndrome 44–"],["Down syndrome 7"],["Dubowitz syndrome 7"],["Dy88 39"],["Epstein–Barr virus 24, 86–"],["IgG 7"],["Fanconi anaemia 51–"],["Griscelli syndrome 68–"],["Executive 60"],["Hu antibodies 50"],["Humax-CD20 42"],["IgA2) 45"],["IgA nephropathy 210, 30"],["IgD 45"],["Jo-1 antibodies 50"],["Kawasaki syndrome 317–1"],["Ki antibodies 50"],["Ku antibodies 504–"],["Kveim test 33"],["La antibodies 50"],["LymphoStat-B 42"],["Ma antibodies 50"],["Authority (MHRA) 59"],["Mi-2 antibodies 50"],["Monday morning fever 16"],["Monospot 8"],["MuSK antibodies 50"],["Netherton syndrome 7"],["Phadia systems 53"],["Ri antibodies 52"],["Ro antibodies 52"],["Satoyoshi syndrome 34"],["Scl-70 antibodies 52"],["Seckel syndrome 7"],["Seemanova syndrome 5"],["Shewart chart 60"],["Sp100 antibodies 52"],["Tr antibodies 53"],["Turner syndrome 7"],["Network (UKPIN) 60"],["IgG 55"],["Waardenburg syndrome 6"],["Westgard rules 60"],["Zic4 antibodies 53"],["Yo antibodies 53"],["Youden chart 60"]]